{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:05:29Z","timestamp":1761843929233},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,11,12]],"date-time":"2009-11-12T00:00:00Z","timestamp":1257984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s00428-009-0850-7","type":"journal-article","created":{"date-parts":[[2009,11,11]],"date-time":"2009-11-11T07:17:47Z","timestamp":1257923867000},"page":"505-515","source":"Crossref","is-referenced-by-count":25,"title":["Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort"],"prefix":"10.1007","volume":"455","author":[{"given":"Stina","family":"Syrj\u00e4nen","sequence":"first","affiliation":[]},{"given":"Paulo","family":"Naud","sequence":"additional","affiliation":[]},{"given":"Luis","family":"Sarian","sequence":"additional","affiliation":[]},{"given":"Sophie","family":"Derchain","sequence":"additional","affiliation":[]},{"given":"Cecilia","family":"Roteli-Martins","sequence":"additional","affiliation":[]},{"given":"Adhemar","family":"Longatto-Filho","sequence":"additional","affiliation":[]},{"given":"Silvio","family":"Tatti","sequence":"additional","affiliation":[]},{"given":"Margherita","family":"Branca","sequence":"additional","affiliation":[]},{"given":"Mojca","family":"Er\u017een","sequence":"additional","affiliation":[]},{"given":"L. S.","family":"Hammes","sequence":"additional","affiliation":[]},{"given":"S.","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Kari","family":"Syrj\u00e4nen","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,11,12]]},"reference":[{"key":"850_CR1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","volume":"384","author":"H zur Hausen","year":"2009","unstructured":"zur Hausen H (2009) Papillomaviruses in the causation of human cancers\u2014a brief historical account. Virology 384:260\u2013265","journal-title":"Virology"},{"key":"850_CR2","first-page":"21","volume":"65","author":"KJ Syrj\u00e4nen","year":"1987","unstructured":"Syrj\u00e4nen KJ (1987) Biology of human papillomavirus (HPV) infections and their role in squamous cell carcinogenesis. Med Biol 65:21\u201339","journal-title":"Med Biol"},{"key":"850_CR3","first-page":"1","volume-title":"Papillomavirus infections in human pathology","author":"K Syrj\u00e4nen","year":"2000","unstructured":"Syrj\u00e4nen K, Syrj\u00e4nen S (2000) Papillomavirus infections in human pathology. Wiley, New York, pp 1\u2013615"},{"issue":"Suppl","key":"850_CR4","first-page":"S7","volume":"16","author":"S Syrj\u00e4nen","year":"2008","unstructured":"Syrj\u00e4nen S, Syrj\u00e4nen K (2008) The history of papillomavirus research. Cent Eur J Public Health 16(Suppl):S7\u201313","journal-title":"Cent Eur J Public Health"},{"key":"850_CR5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, de Sanjose S et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518\u2013527","journal-title":"N Engl J Med"},{"key":"850_CR6","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","volume":"366","author":"GM Cliffort","year":"2005","unstructured":"Cliffort GM, Gallus S, Herrero R et al (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for research on Cancer HPV prevalence surveys: pooled analysis. Lancet 366:991\u2013998","journal-title":"Lancet"},{"key":"850_CR7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/07853899909115976","volume":"31","author":"SM Syrj\u00e4nen","year":"1999","unstructured":"Syrj\u00e4nen SM, Syrj\u00e4nen KJ (1999) New concepts on the role of human papillomavirus in cell cycle regulation. Ann Med 31:175\u2013187","journal-title":"Ann Med"},{"key":"850_CR8","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/S0959-8049(02)00462-8","volume":"38","author":"M Knebel Doeberitz von","year":"2002","unstructured":"von Knebel Doeberitz M (2002) New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 38:2229\u20132242","journal-title":"Eur J Cancer"},{"key":"850_CR9","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.1128\/JVI.78.21.11451-11460.2004","volume":"78","author":"K Munger","year":"2004","unstructured":"Munger K, Baldwin A, Edwards KM et al (2004) Mechanisms of human papillomavirus-induced oncogenesis. J Virol 78:11451\u201311460","journal-title":"J Virol"},{"key":"850_CR10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.pgp.0000139639.79105.40","volume":"23","author":"M Branca","year":"2004","unstructured":"Branca M, Ciotti M, Santini D et al (2004) p16INK4A expression is related to grade of CIN and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome. Int J Gynecol Pathol 23:354\u2013365","journal-title":"Int J Gynecol Pathol"},{"key":"850_CR11","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1158\/1055-9965.EPI-06-0086","volume":"15","author":"R Santopietro","year":"2006","unstructured":"Santopietro R, Shabalova IP, Petrovichev N et al (2006) Cell cycle regulators p105, p107, Rb2\/p130, E2F4, p21CIP1\/WAF1, cyclin-A in predicting CIN, high-risk human papillomavirus infections and their outcome in women screened in three New Independent States of the Former Soviet Union. Cancer Epidemiol Biomark Prev 15:1250\u20131256","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"850_CR12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.vaccine.2005.09.002","volume":"24S","author":"M Stanley","year":"2006","unstructured":"Stanley M (2006) Immune responses to human papillomavirus. Vaccine 24S:16\u201322","journal-title":"Vaccine"},{"key":"850_CR13","first-page":"459","volume-title":"Papillomavirus infections in human pathology","author":"K Syrj\u00e4nen","year":"2000","unstructured":"Syrj\u00e4nen K (2000) Immunology of HPV infections and prospects for vaccination. Chapter 21. In: Syrj\u00e4nen K, Syrj\u00e4nen S (eds) Papillomavirus infections in human pathology. Wiley, New York, pp 459\u2013490"},{"key":"850_CR14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal MR, Coffman RL et al (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683\u2013765","journal-title":"Annu Rev Immunol"},{"key":"850_CR15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","volume":"226","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Zhang X (2008) Interleukin-10: new perspectives on an old cytokine. Immunol Rev 226:205\u2013218","journal-title":"Immunol Rev"},{"key":"850_CR16","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1084\/jem.170.6.2081","volume":"170","author":"DF Fiorentino","year":"1989","unstructured":"Fiorentino DF, Bond MW, Mosmann TR (1989) Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170:2081\u20132095","journal-title":"J Exp Med"},{"key":"850_CR17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/vim.2006.19.481","volume":"19","author":"JM Alcocer-Gonzalez","year":"2006","unstructured":"Alcocer-Gonzalez JM, Berumen J, Tamez-Guerra R et al (2006) In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells. Viral Immunol 19:481\u2013491","journal-title":"Viral Immunol"},{"key":"850_CR18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1084\/jem.174.4.915","volume":"174","author":"R Waal Malefyt de","year":"1991","unstructured":"de Waal Malefyt R, Haanen J, Spits HM et al (1991) Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 174:915\u2013920","journal-title":"J Exp Med"},{"key":"850_CR19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jnci\/89.3.245","volume":"89","author":"M Clerici","year":"1997","unstructured":"Clerici M, Merola M, Ferrario E et al (1997) Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 89:245\u201350","journal-title":"J Natl Cancer Inst"},{"key":"850_CR20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0959-8049(98)00371-2","volume":"35","author":"TD Gruijl de","year":"1999","unstructured":"de Gruijl TD, Bontkes HJ, van den Muysenberg AJ et al (1999) Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix. Eur J Cancer 35:490\u2013497","journal-title":"Eur J Cancer"},{"key":"850_CR21","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1128\/JVI.74.10.4729-4737.2000","volume":"74","author":"AD Santin","year":"2000","unstructured":"Santin AD, Hermonat PL, Ravaggi A et al (2000) Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes. J Virol 74:4729\u20134737","journal-title":"J Virol"},{"key":"850_CR22","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.1158\/0008-5472.CAN-04-1091","volume":"64","author":"A Kobayashi","year":"2004","unstructured":"Kobayashi A, Greenblatt RM, Anastos K et al (2004) Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Cancer Res 64:6766\u20136774","journal-title":"Cancer Res"},{"key":"850_CR23","first-page":"3469","volume":"25","author":"K Syrj\u00e4nen","year":"2005","unstructured":"Syrj\u00e4nen K, Naud P, Derchain SM et al (2005) Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study. Anticancer Res 25:3469\u20133480","journal-title":"Anticancer Res"},{"key":"850_CR24","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1159\/000326195","volume":"49","author":"A Longatto-Filho","year":"2005","unstructured":"Longatto-Filho A, Maeda MYS, Er\u017een M et al (2005) Conventional PAP smear and liquid-based cytology as screening tools in low-resource settings of Latin America. Experience of the Latin American Screening Study. Acta Cytol 49:500\u2013506","journal-title":"Acta Cytol"},{"key":"850_CR25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1258\/0969141054855328","volume":"12","author":"L Sarian","year":"2005","unstructured":"Sarian L, Derchain SM, Naud P et al (2005) Evaluation of visual inspection with acetic acid (VIA), Lugol\u2019s iodine (VILI) cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin American Screening) study. J Med Screen 12:142\u2013149","journal-title":"J Med Screen"},{"key":"850_CR26","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1525-1438.2006.00582.x","volume":"16","author":"A Longatto-Filho","year":"2006","unstructured":"Longatto-Filho A, Er\u017een M, Branca M et al (2006) Human papillomavirus (HPV) testing as an optional screening tool in low-resource settings of Latin America. Experience from the LAMS study. Int J Gynecol Cancer 16:955\u2013962","journal-title":"Int J Gynecol Cancer"},{"key":"850_CR27","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/IGC.0b013e3181a834fe","volume":"19","author":"K Syrj\u00e4nen","year":"2009","unstructured":"Syrj\u00e4nen K, Shabalova I, Naud P et al (2009) Persistent high-risk human papillomavirus (HPV) infections and other endpoint markers of progressive cervical disease among women prospectively followed-up in the NIS and LAMS cohorts. Int J Gynecol Cancer 19:934\u2013942","journal-title":"Int J Gynecol Cancer"},{"key":"850_CR28","first-page":"9","volume":"59","author":"PT Seed","year":"2001","unstructured":"Seed PT, Tobias A (2001) Summary statistics for diagnostic tests. Stata Techn Bull 59:9\u201312","journal-title":"Stata Techn Bull"},{"key":"850_CR29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000299290","volume":"16","author":"KJ Syrj\u00e4nen","year":"1983","unstructured":"Syrj\u00e4nen KJ (1983) Immunocompetent cells in uterine cervical lesions of human papillomavirus (HPV) origin. Gynecol Obstet Invest 16:327\u2013340","journal-title":"Gynecol Obstet Invest"},{"key":"850_CR30","first-page":"190","volume":"61","author":"M V\u00e4yrynen","year":"1985","unstructured":"V\u00e4yrynen M, Syrj\u00e4nen K, M\u00e4ntyj\u00e4rvi R et al (1985) Immunophenotypes of lymphocytes in prospectively followed up human papillomavirus lesions of the cervix. Genitourin Med 61:190\u2013196","journal-title":"Genitourin Med"},{"key":"850_CR31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0020-7292(84)90070-5","volume":"22","author":"M V\u00e4yrynen","year":"1984","unstructured":"V\u00e4yrynen M, Syrj\u00e4nen K, M\u00e4ntyj\u00e4rvi R et al (1984) Langerhans cells in human papillomavirus (HPV) lesions of the uterine cervix identified by the monoclonal antibody OKT-6. Int J Gynaecol Obstet 22:375\u2013383","journal-title":"Int J Gynaecol Obstet"},{"key":"850_CR32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/00016348609158369","volume":"65","author":"K Syrj\u00e4nen","year":"1986","unstructured":"Syrj\u00e4nen K, V\u00e4yrynen M, M\u00e4ntyj\u00e4rvi R et al (1986) Natural killer (NK) cells with HNK-1 phenotype in the cervical biopsies of women followed-up for human papillomavirus (HPV) lesions. Acta Obstet Gynecol Scand 65:139\u2013145","journal-title":"Acta Obstet Gynecol Scand"},{"key":"850_CR33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF00570755","volume":"234","author":"K Syrj\u00e4nen","year":"1984","unstructured":"Syrj\u00e4nen K, V\u00e4yrynen M, Castren O et al (1984) The relation between the type of immunoreactive cells found in human papillomavirus (HPV) lesions of the uterine cervix and the subsequent behaviour of these lesions. Arch Gynecol 234:189\u2013196","journal-title":"Arch Gynecol"},{"key":"850_CR34","first-page":"181","volume":"32","author":"K Syrj\u00e4nen","year":"1985","unstructured":"Syrj\u00e4nen K, V\u00e4yrynen M, Hippel\u00e4inen M et al (1985) The in situ immunological reactivity and its significance in the clinical behaviour of the cervical human papillomavirus lesions. Neoplasma 32:181\u2013190","journal-title":"Neoplasma"},{"key":"850_CR35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2567.2004.01988.x","volume":"113","author":"LM Williams","year":"2004","unstructured":"Williams LM, Ricchetti G, Sarma U et al (2004) Interleukin-10 suppression of myeloid cell activation\u2014a continuing puzzle. Immunology 113:281\u2013292","journal-title":"Immunology"},{"key":"850_CR36","first-page":"533","volume":"49","author":"R Mindiola","year":"2008","unstructured":"Mindiola R, Caulejas D, Nunez-Troconis J et al (2008) Increased number of IL-2, IL-2 receptor and IL-10 positive cells in premalignant lesions of the cervix. Invest Clin 49:533\u2013545","journal-title":"Invest Clin"},{"key":"850_CR37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1365-2249.1998.00639.x","volume":"113","author":"SL Giannini","year":"1998","unstructured":"Giannini SL, Al-Saleh W, Piron H et al (1998) Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression. Clin Exp Immunol 113:183\u2013189","journal-title":"Clin Exp Immunol"},{"key":"850_CR38","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/ijc.24117","volume":"124","author":"ME Scott","year":"2009","unstructured":"Scott ME, Ma Y, Kuzmich L, Moscicki AB (2009) Diminished IFN-gamma and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3. Int J Cancer 124:1379\u20131383","journal-title":"Int J Cancer"},{"key":"850_CR39","first-page":"265","volume":"27","author":"M Branca","year":"2008","unstructured":"Branca M, Ciotti M, Giorgi C et al (2008) Predicting high-risk human papillomavirus (HPV) infection, progression of cervical intraepithelial neoplasia (CIN) and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modelling. Int J Gynecol Pathol 27:265\u2013273","journal-title":"Int J Gynecol Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-009-0850-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-009-0850-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-009-0850-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:35:55Z","timestamp":1559064955000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-009-0850-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["850"],"URL":"https:\/\/doi.org\/10.1007\/s00428-009-0850-7","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,12]]}}}